Investor relations
Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is the global leader in veterinary diagnostics, software, and water microbiology testing.
Q3 2022 Results - November 1
Corporate Responsibility Report
Corporate Responsibility is fundamental to how IDEXX operates as a business, employer, supplier, customer, and member of the community.
Investor resources
Upcoming earnings dates
Q4 2022: February 6
Investor resources
Investor Relations
One IDEXX Drive
Westbrook, Maine 04092
1-207-556-8155 or 1-800-548-6733
Fax: 1-207-556-4427
Email
Latest news
IDEXX Laboratories Announces Third Quarter Results
IDEXX Announces Second Quarter Results
IDEXX Announces New Goals in Its 2021 Corporate Responsibility Report and Advances Progress on Environmental, Social, and Governance Initiatives
Read more
IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases
Read more
IDEXX to Present at Stifel Conference and IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
Read more
IDEXX Announces First Quarter Results
IDEXX to Present at Two Upcoming Institutional Investor Conferences
Read more
IDEXX Announces Fourth Quarter and Full Year 2021 Results
IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions
Read more
IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering
Read more
IDEXX Acquires ezyVet
Read more
IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Read more
IDEXX Elects Dr. Asha S. Collins to Board of Directors
Read more
IDEXX Provides U.S. Companion Animal Market Trends Update
Read more
View the U.S. Companion Animal Market Trends Snapshot
IDEXX Launches Groundbreaking New ProCyte One Hematology Analyzer with Dramatically Simplified User Experience
Read more
IDEXX Expands ImageVue Digital Imaging Portfolio, Making Enhanced Radiation Safety and Superior Diagnostic Image Quality Affordable to More Veterinarians
Read more
OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Read more
IDEXX Provides U.S. Companion Animal Market Trends Update
Read more
View the U.S. Companion Animal Market Trends Snapshot
OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Read more
IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians
Read more
Events and presentations
IDEXX Third Quarter 2022 Earning Conference Call
November 1, 2022, 8:30 am EDT
IDEXX Investor Day (webcast replay)
Thursday, August 11, 2022
View presentation
IDEXX Second Quarter 2022 Earnings Conference Call
August 2, 2022, 8:30 am EDT
Stifel Jaws & Paws Conference
Wednesday, June 1, 2022, 1:50-2:20 pm EDT
IDEXX 2022 Annual Meeting of Shareholders: Answers to Shareholders’ Questions
View document
IDEXX First Quarter 2022 Earnings Conference Call
Wednesday, May 4, 2022, 8:30 am EDT
43rd Annual Raymond James Institutional Investors Conference
Monday, March 7, 2022, 11:00 am EST
View presentation
IDEXX Fourth Quarter 2021 Earnings Conference Call
Wednesday, February 2, 2022, 8:30 am EST
IDEXX Third Quarter 2021 Earnings Conference Call
Tuesday, November 2, 2021, 8:30 am EDT
IDEXX Virtual Investor Day
Thursday, August 12, 2021, 10:00 am EDT
View presentation
IDEXX Second Quarter 2021 Earnings Conference Call
Friday, July 30, 2021, 8:30 am EDT
*Pricing delayed by 20 minutes